The IL-6/JAK/Stat3 feed-forward loop drives tumorigenesis and metastasis.
about
Cancer as a Proinflammatory Environment: Metastasis and CachexiaImmune cell interplay in colorectal cancer prognosisPreclinical validation of interleukin 6 as a therapeutic target in multiple myelomaThe dual role of tumor lymphatic vessels in dissemination of metastases and immune response developmentBreast Cancer Brain Metastases: Clonal Evolution in Clinical Context.A novel role for ezrin in breast cancer angio/lymphangiogenesis.The impact of human adipose tissue-derived stem cells on breast cancer cells: implications for cell-assisted lipotransfers in breast reconstruction.Challenging a Misnomer? The Role of Inflammatory Pathways in Inflammatory Breast CancerC-X-C motif chemokine 12/C-X-C chemokine receptor type 7 signaling regulates breast cancer growth and metastasis by modulating the tumor microenvironment.Surgery-induced wound response promotes stem-like and tumor-initiating features of breast cancer cells, via STAT3 signalingTherapeutic CK2 inhibition attenuates diverse prosurvival signaling cascades and decreases cell viability in human breast cancer cells.The cytokine IL-6 reactivates breast stromal fibroblasts through transcription factor STAT3-dependent up-regulation of the RNA-binding protein AUF1.CCR7 regulates cell migration and invasion through JAK2/STAT3 in metastatic squamous cell carcinoma of the head and neck.WP1066 sensitizes oral squamous cell carcinoma cells to cisplatin by targeting STAT3/miR-21 axisTargeting JAK1/STAT3 signaling suppresses tumor progression and metastasis in a peritoneal model of human ovarian cancerBreast cancer cells condition lymphatic endothelial cells within pre-metastatic niches to promote metastasisHedyotis diffusa Willd. extract suppresses proliferation and induces apoptosis via IL-6-inducible STAT3 pathway inactivation in human colorectal cancer cells.Effect of vascular formed endothelial cell network on the invasive capacity of melanoma using the in vitro 3D co-culture patterning model.Differential roles of STAT3 in the initiation and growth of lung cancerTargeted Blockade of JAK/STAT3 Signaling Inhibits Ovarian Carcinoma Growth.Constitutive phosphorylated STAT3-associated gene signature is predictive for trastuzumab resistance in primary HER2-positive breast cancer.Identification of Novel Biomarkers for Metastatic Colorectal Cancer Using Angiogenesis-Antibody Array and Intracellular Signaling Array.The Mycoplasma hyorhinis p37 Protein Rapidly Induces Genes in Fibroblasts Associated with Inflammation and Cancer.Interleukin-6 Stimulates Defective Angiogenesis.Inhibition of the autocrine IL-6-JAK2-STAT3-calprotectin axis as targeted therapy for HR-/HER2+ breast cancers.Characterization and Clinical Implication of Th1/Th2/Th17 Cytokines Produced from Three-Dimensionally Cultured Tumor Tissues Resected from Breast Cancer Patients.Modeling selective elimination of quiescent cancer cells from bone marrow.IL-6/STAT3 signaling pathway is activated in plasma cell mastitis.Role of a polyphenol-enriched preparation on chemoprevention of mammary carcinoma through cancer stem cells and inflammatory pathways modulationInterplay between YB-1 and IL-6 promotes the metastatic phenotype in breast cancer cells.Interleukin 6 trigged ataxia-telangiectasia mutated activation facilitates lung cancer metastasis via MMP-3/MMP-13 up-regulationSelf-renewal of CD133(hi) cells by IL6/Notch3 signalling regulates endocrine resistance in metastatic breast cancer.Tumour exosome integrins determine organotropic metastasis.Constitutive activation of STAT3 in breast cancer cells: A review.Death receptor 6 (DR6) is required for mouse B16 tumor angiogenesis via the NF-κB, P38 MAPK and STAT3 pathways.Cancer prevention and therapy through the modulation of the tumor microenvironment.A novel tumor-promoting mechanism of IL6 and the therapeutic efficacy of tocilizumab: Hypoxia-induced IL6 is a potent autophagy initiator in glioblastoma via the p-STAT3-MIR155-3p-CREBRF pathwayRandomized, Double-Blind, Phase II Study of Ruxolitinib or Placebo in Combination With Capecitabine in Patients With Metastatic Pancreatic Cancer for Whom Therapy With Gemcitabine Has Failed.Cancer subclonal genetic architecture as a key to personalized medicine.Targeted gene silencing of CCL2 inhibits triple negative breast cancer progression by blocking cancer stem cell renewal and M2 macrophage recruitment.
P2860
Q26778324-7A8DBFD4-E628-4864-9BB5-048D07C2B54DQ26781453-D86EFFF4-CC29-4773-A615-B060BCF83427Q27027729-C2D3FF94-2DA9-417F-A8D0-F95D81A24076Q28076945-559ABE54-67EA-4BAF-8D52-C258F37E425AQ30238959-39BEFE86-6BD4-4ACF-AC8B-A3840CC48650Q30617722-94293040-E398-4509-AB0C-9624D3D44A41Q33730051-387086FD-51C4-4779-BA74-2AE2AD7743E0Q33760216-FD23193D-8FDF-4D31-9E30-0827A1BB4A4FQ33827026-DC175DD3-DD02-426B-9AE1-7D2E192CACBEQ34227685-354C730C-73B1-4D11-930A-2770C8999214Q34227776-68AA3FB7-3CCC-4682-A061-7E8871EF4D56Q34467457-E93E2477-876E-4297-B84D-4EB72C2E64A3Q34487441-FDCC5890-F527-405A-9E97-702823ECA7B4Q34719683-E0B8E10A-64EF-48FD-88D8-26F01C2CBE4CQ35064627-33592A3D-82DE-43F5-9D9C-7234C24EF2C2Q35154624-78A01670-D83C-4BDE-93B1-C4EB37149D18Q35167797-29E62938-1C97-4466-8556-37951D217859Q35212326-3CD4E358-1D35-4873-AC73-B9503AEB0F41Q35288058-8AC32711-F2E3-467C-930F-B56182B74337Q35374753-D8F588BD-34BF-465D-8C00-0A3AD2CD63F7Q35733734-42EB8B65-ED8C-4F12-BEDC-0FE938B4784DQ35741252-989539DE-7F63-4594-893E-C6EFDDA18633Q35825790-DC5EBC03-68E4-4C31-A172-019D6F3A542DQ35923153-87854495-C21D-4D1A-B8CD-340BE53ECC42Q35952745-781826A8-EDA1-41B4-9D69-6B9976992F6FQ36038030-66528014-BBF8-45F8-95AF-E89EBC3E0F0CQ36360112-AF212441-4893-4ABD-A4C7-66D4D3562DD9Q36375146-F3CAD6ED-F064-4055-A9A0-676A020C8D5FQ36461628-396F4413-36C4-4CBA-AB59-1A0934D8136BQ36546008-7DBB1C29-115A-49F2-BC53-F8438999F65AQ36562147-D11BB38A-5889-47A3-93AE-CEF9B04AFA2BQ36564710-BFF9E977-74A8-4A9B-9DB5-D6755C49D2AAQ36677568-1D7E2C35-CB2C-4585-9C85-FE994278B19CQ36711689-21EAFD7B-66F8-442B-A548-500D13FD2FBEQ36748713-03FA38DC-5E68-4376-99F2-22157D1D288FQ37058267-489BD185-9E6D-4894-A5F5-B432D2D6F58DQ37189154-7889786C-81CB-4304-A71B-8F38DF8E9645Q37384293-9EA9682E-0C74-430A-8F6F-407C97F5CD67Q37448116-E1F08993-D938-475E-A253-0B2652B0AF79Q37580230-5FD948EA-34E7-4DE2-ABDC-8432CC043EF3
P2860
The IL-6/JAK/Stat3 feed-forward loop drives tumorigenesis and metastasis.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
The IL-6/JAK/Stat3 feed-forward loop drives tumorigenesis and metastasis.
@en
type
label
The IL-6/JAK/Stat3 feed-forward loop drives tumorigenesis and metastasis.
@en
prefLabel
The IL-6/JAK/Stat3 feed-forward loop drives tumorigenesis and metastasis.
@en
P2093
P2860
P50
P356
P1433
P1476
The IL-6/JAK/Stat3 feed-forward loop drives tumorigenesis and metastasis.
@en
P2093
David Lyden
Dennis Huszar
Donatella Santini
Eirini Bournazou
Gregoire Altan-Bonnet
Jacqueline Bromberg
Jared Wels
Jesse Cotari
Katia Manova
Laura Daly
P2860
P304
P356
10.1593/NEO.13706
P577
2013-07-01T00:00:00Z